Download full report with analyst certification and important disclosures
Mar 29 2019, 07:40 GMT
Ratings and price correct at time of issue
Company | Rating | Date | Previous Rating | Date | Closing Price |
---|---|---|---|---|---|
Corbion | NEUTRAL | 29/04/11 | Outperform | 01/09/10 | 2688c |
DSM-Firmenich | OUTPERFORM | 11/02/15 | Neutral | 16/07/14 | 9706c |
The evolution of feed composition in aquaculture has led to a steep decline in Omega-3 levels in farmed salmon. This has catalysed the emergence of sustainable and novel high Omega-3 ingredients with an estimated market potential of c.$2bn. Corbion and DSM are on a pathway to commercialising viable algae-based alternatives. We believe this is not a winner-takes-all opportunity. While not without challenges (price, efficacy, yield), we are optimistic that both projects can generate value for shareholders.
Mar 29 2019, 07:40 GMT